EW
BSTC

Evoke Wealth’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Evoke Wealth’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-152
Closed -$8.65K – 1424
2019
Q4 		$8.65K Hold
152
– – ﹤0.01% 788
2019
Q3 		$8.13K Buy
+152
New +$8.85K ﹤0.01% 873

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Evoke Wealth's BSTC Position: Q1 2020 in Review

Evoke Wealth sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2020, closing a stake of 152 shares — an estimated $8.65K sold.

Evoke Wealth first reported a position in BSTC in Q3 2019 and held it in 2 quarters. The position peaked at $8.65K in Q4 2019. 113 funds tracked by Wall St. Rank hold BSTC as of Q1 2020.

  • Evoke Wealth reported no remaining BioSpecifics Technologies Corp. position as of Q1 2020 after selling out during the quarter.
  • Evoke Wealth sold 152 BioSpecifics Technologies Corp. shares in Q1 2020, an estimated $8.65K.
  • Evoke Wealth first reported a position in BioSpecifics Technologies Corp. in Q3 2019 and held it in 2 quarters.
  • Evoke Wealth's BioSpecifics Technologies Corp. position peaked at $8.65K in Q4 2019.
  • 113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2020.

Based on Evoke Wealth's 13F filing for Q1 2020, filed 7 May 2020.